Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2022 Earnings Call Transcript

Blueprint Medicines Corporation (NASDAQ:BPMC) Q4 2022 Earnings Call Transcript February 16, 2023

Operator: Good morning, and welcome to the Blueprint Medicines Conference Call. At this time, all participants are in listen-only-mode. Following the formal remarks, we will open the call up for your questions. Please be advised that this call is being recorded. At this time, I’d like to turn over to Jenna Cohen, Head of Investor Relations at Blueprint Medicines. Please proceed.

Jenna Cohen:...